Report : Asia Pacific Neurosurgical Robotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component [Equipment/System (Robot Machines, Navigation System, Planner & Simulators, and Others), Accessories, and Services], Application [Spinal (Laminectomy, Discectomy, Spinal Fusion, Disc Replacement, Foraminotomy, and Others) and Cranial (Craniotomy, Brain Biopsy, Thermal ablation of Seizure and Others)], Surgery Type (Minimally Invasive and Open Surgery), and End User (Hospitals, Specialty Clinics, and Others)
At 17.1% CAGR, the Asia Pacific Neurosurgical Robotics Market is speculated to be worth US$ 1,127.73 Million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific neurosurgical robotics market was valued at US$ 438.08 million in 2022 and is expected to reach US$ 1,127.73 million by 2028, registering an annual growth rate of 17.1% from 2022 to 2028. Rising number of product developments and approvals including rising nanorobots technology are the critical factors attributed to the market expansion.
The neurosurgical robotics market has the presence of many small and big companies. New component launch, regional expansion, product approval, and technological advancement are among the strategies adopted by companies to enlarge their market shares. Neurosurgical robots have become safer and more effective than ever with continuous innovations and technological advancements, boosting their acceptance among the masses. The active participation of market players in development activities, followed by increased product approvals by regulatory bodies, would offer lucrative opportunities for the growth of the neurosurgical robotics market in the coming years.
On the contrary, high installation costs of neurosurgical robotics hurdles the growth of Asia Pacific neurosurgical robotics market.
- Based on component, the Asia Pacific neurosurgical robotics market is segmented into equipment/system, accessories, and services. The equipment/system segment is further segmented into robot machines, navigation system, planner & simulators, and others. The accessories segment is anticipated to hold the largest share of the market in 2022 with a share of 44.7%, amassing US$ 195.68 million. It is projected to garner US$ 499.65 million by 2028 to expand at 16.9% CAGR during 2022–2028.
The Asia Pacific neurosurgical robotics market, based on application, is segmented into spinal and cranial. Spinal application is further segmented into spinal fusion, laminectomy, disc replacement, discectomy, foraminotomy, and others. The cranial segment is also subsegmented into brain biopsy, thermal ablation of seizure, surgical treatment of movement disorders, and others. In 2022, the spinal segment is anticipated to hold the largest share of the market, with a share of 63.0%, amassing US$ 275.96 million. It is projected to garner US$ 726.77 million by 2028 to expand at 17.5% CAGR during 2022–2028.
The Asia Pacific neurosurgical robotics market, based on surgery type, is segmented into open and minimally invasive. In 2022, the minimally invasive segment is anticipated to hold a larger share of the market in 2022 with a share of 84.1%, amassing US$ 368.42 million. It is projected to garner US$ 999.92 million by 2028 to expand at 18.1.% CAGR during 2022–2028.
- Based on end user, the Asia Pacific neurosurgical robotics market is segmented into hospitals, specialty centers, and others. In 2022, the hospitals segment is anticipated to hold the largest share of the market with a share of 68.5%, amassing US$ 300.24 million. It is projected to garner US$ 760.55 million by 2028 to expand at 16.8% CAGR during 2022–2028.
Our regional analysis states that China captured 35.4% market share in 2022. It was assessed at US$ 155.23 million in 2022 and is likely to hit US$ 409.42 million by 2028, exhibiting a CAGR of 17.5% during the forecast period.
Key players dominating the Asia Pacific neurosurgical robotics market are Accuray Incorporated; B. Braun Melsungen AG; Brainlab AG; Brain Navi Biotechnology Co., Ltd.; Globus Medical, Inc.; Medtronic; Renishaw plc; NuVasive, Inc.; and Zimmer Biomet.
Below are listed a few recent key developments by major market players:
- In April 2022, Medtronic announced a partnership to interface Surgical Theater's SyncAR augmented reality (AR) technology with Medtronic's StealthStation S8 surgical navigation system.
- In Nov 2020, Medtronic announced that it had completed its friendly tender offer for France-based Medicrea International
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com